
Allergan Breast Implants
Allergan Breast Implants
If you received textured or smooth implants manufactured by Allergan, you may be affected by this class action lawsuit. Please fill out the form below to get in touch with us. Joining our contact list creates no financial obligation and we will keep all the information that you provide to us confidential.
- Current Status
- Overview
Current Status
Pursuant to the Order of the Superior Court of Justice, the notice period advising of the certification of the lawsuit known as Kibalian et al v. Allergan PLC et al (Corut File No. Cv-19-00620507-00CP) began on May 14, 2025.
If you wish to remain a member of the class action, you do not need to take any steps at this time.
If you do not wish to participate in the class action and be bound by any future judgment or settlement of the class action, you must complete and submit an opt-out form and deliver it to the administrator on or behalf the Opt-Out Deadline of June 16, 2025. Opt-out forms are available from the Administrator at www.AllerganBreastImplants.Ca or below.
For more information of your legal rights, please refer to the Long-Form Notice or visit www.AllerganBreastImplants.ca.
Short-form notice in English or Short-form notice in French
Long-form notice in English or Long-form notice in French
Opt-out form in English or Opt-out form in French
Overview
This class action arises from Allergan’s alleged failure to disclose health risks associated with their breast implants, sold in Canada, including in British Columbia. Class action lawsuits were commenced in British Columbia, Ontario, and Quebec, collectively the National Allergan Class Actions.
Health Canada has recently suspended Allergan’s license for its Biocell breast implants. The full details of the Health Canada recall can be found here.
Our firm is seeking compensation for persons who underwent implant surgery with Allergan breast implants without being provided with full and adequate disclosure of the risks associated with the implants, including the risk of Anaplastic Large Cell Lymphoma (“BIA-ALCL”) and for related financial losses associated with these health issues.
To access the court documents, click on the links below:
• Notice of Civil Claim (BC)
• Statement of Claim (ON)
• Application to Authorize (QC)
Case Name: | Bunsko v. Allergan Inc., SCBC No. 196308, Vancouver Registry (the “BC Allergan Class Action”) |
Kibalian v. Allergan PLC, CV-19-00620507-00CP (“the ON Allergan Class Action”) | |
Basal v. Allergan Inc., No: 500-06-000966-198 (“the QC Allergan Class Action”) | |
Together the BC Allergan Class Action, the ON Allergan Class Action, the QC Allergan Class Action will be called “the National Allergan Class Actions” | |
Court: | The BC Allergan Class Action was filed in the Supreme Court of British Columbia |
Date Filed: | The BC Allergan Class Action was filed May 31, 2019. |
Class Members: | Collectively the class has been defined as “All persons residing in Canada who were implanted with breast implants manufactured and distributed by Allergan plc and several of its affiliates”. |
Allergan Form
Note: You are not obliged to fill in this form to participate in this class action. If you choose to do so, you are not retaining RHE LLP to act on your behalf. Providing the information requested does not make you a client of RHE LLP. All information submitted will be treated as confidential and will only be released as required by law or as you may consent.
I provide my consent and agree herein to receive communications from RHE LLP, which may include announcements regarding class actions, practice updates, newsletters, publications, event invitations or other information that may be of interest. I understand that consent to receive these electronic communications may be withdrawn at any time by emailing reception@rhelaw.com.